← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...
HomeStocksXNCRPrice Target
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

Xencor, Inc. (XNCR) Price Target Analysis

Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026

Current Price
$12.77
Market reference
Price Target
$28.75
+125.1% Upside
Target Range
$18.00 — $42.00
Very wide disagreement
Analyst Rating
Buy
27 analysts
Forward P/E—
Trailing P/E-10.3x
Forward PEG—
Implied Growth-124.2%
Median Target$27.50
Analyst Spread83.5%

Analysts see +125.1% upside to their consensus target of $28.75. The bullish rating consensus aligns with positive price target gap.

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$12.77
Consensus$28.75
High$42.00
Low$18.00
Bear Case
$18
+41.0%
Consensus
$29
+125.1%
Bull Case
$42
+228.9%

Analyst Ratings Distribution

Breakdown of 27 published analyst recommendations for XNCR

25/27 analysts are bullish
+46
BearishBullish
Weighted analyst sentiment score based on 27 ratings
ConsensusBuy
Coverage27 Analysts
Net Score+46
Bull / Bear93% / 4%
Strong Buy14%
Buy2489%
Hold14%
Sell14%
Strong Sell00%
Strong Buy
14%
Buy
2489%
Hold
14%
Sell
14%
Strong Sell
00%
Recommendation Mix93% Buy · 4% Hold · 4% Sell
Buy (25)Hold (1)Sell (1)

XNCR Price Target Analysis

Updated February 28, 2026

As of February 28, 2026, Xencor, Inc. (XNCR) has a Wall Street consensus price target of $28.75, based on estimates from 27 covering analysts. With the stock currently trading at $12.77, this represents a potential upside of +125.1%. The company has a market capitalization of $918M.

Analyst price targets range from a low of $18.00 to a high of $42.00, representing a 83% spread in expectations. The median target of $27.50 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.

The current analyst consensus rating is Buy, with 25 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 1 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.

From a valuation perspective, XNCR trades at a trailing P/E of -10.3x. Analysts expect EPS to grow -124.2% over the next year.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside+97.6%
Avg Forward P/E17.3x
Peers with Coverage10 / 10
CompanyMarket CapPriceTargetUpsideRatingFwd P/EAnalysts
XNCRXencor, Inc.
$918M$12.77$28.75+125.1%Buy—27
REGNRegeneron Pharmaceuticals, Inc.$107.6B$781.67$857.17+9.7%Buy17.3x48
CNTACentessa Pharmaceuticals plc$3.6B$26.86$37.33+39.0%Buy—11
IMNMImmunome, Inc.$2.0B$21.86$35.29+61.4%Buy—9
CLDXCelldex Therapeutics, Inc.$2.0B$30.09$24.00-20.2%Buy—19
RXRXRecursion Pharmaceuticals, Inc.$1.9B$3.67$11.00+199.7%Hold—10
NRIXNurix Therapeutics, Inc.$1.6B$15.97$31.22+95.5%Buy—17
ROIVRoivant Sciences Ltd.$1.1B$28.94$31.25+8.0%Buy—14
ABCLAbCellera Biologics Inc.$1.1B$3.61$20.17+458.7%Buy—11
ARVNArvinas, Inc.$975M$13.27$13.17-0.8%Buy—26

Upside Potential Comparison

ABCL
+458.7%
RXRX
+199.7%
XNCR
+125.1%
NRIX
+95.5%
IMNM
+61.4%
CNTA
+39.0%
REGN
+9.7%
ROIV
+8.0%

See XNCR's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is XNCR Undervalued?

See our Bear / Base / Bull DCF models and intrinsic value estimates.

View Valuation

Compare XNCR vs AGIO

See how XNCR stacks up against sector leader Agios Pharmaceuticals, Inc..

Start Comparison

Frequently Asked Questions

What is the XNCR stock price target for 2026?

The consensus Wall Street price target for XNCR is $28.75, representing 125.1% upside from the current price of $12.77. With 27 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is XNCR a buy, sell, or hold?

XNCR has a consensus rating of "Buy" based on 27 Wall Street analysts. The rating breakdown is predominantly bullish, with 25 Buy/Strong Buy ratings. The consensus 12-month price target of $28.75 implies 125.1% upside from current levels.

Is XNCR stock overvalued or undervalued?

XNCR's current price is $12.77 with a consensus target of $28.75 (125.1% implied move). Analyst estimates suggest the stock is undervalued at current levels.

How high can XNCR stock go?

The most bullish Wall Street analyst has a price target of $42 for XNCR, while the most conservative target is $18. The consensus of $28.75 represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover XNCR stock?

XNCR is heavily covered by Wall Street, with 27 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 24 have Buy ratings, 1 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the XNCR stock forecast?

The 12-month XNCR stock forecast based on 27 Wall Street analysts shows a consensus price target of $28.75, with estimates ranging from $18 (bear case) to $42 (bull case). The median consensus rating is "Buy".

Should I buy XNCR stock?

Wall Street analysts are very optimistic on XNCR, with a "Buy" consensus rating and $28.75 price target (125.1% upside). 25 of 27 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do XNCR price targets vary so much?

XNCR analyst price targets range from $18 to $42, a 83% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $28.75 consensus represents the middle ground.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.